Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01785550 · ClinicalTrials.gov registry record
Neuromuscular Ultrasound in ALS
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 40
- Enrollment target
NCT01785550 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 40 participants.
The verdict
NCT01785550 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Amyotrophic Lateral Sclerosis (ALS) is a progressive fatal neurodegenerative disease affecting motor neurons. Early diagnosis is essential for the success of clinical trials and objective biomarkers are needed for monitoring disease progression. Nerve and muscle ultrasound may provide this information. This study will collect pilot data to evaluate the value of muscle and nerve ultrasound to identify and monitor disease progression in ALS.
Interventions
- OTHER Ultrasound of nerve and muscle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01785550
The ClinicalTrials.gov registry entry for NCT01785550 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound of nerve and muscle is the first listed.
NCT01785550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01785550 about?
NCT01785550 is a clinical study titled "Neuromuscular Ultrasound in ALS". Amyotrophic Lateral Sclerosis (ALS) is a progressive fatal neurodegenerative disease affecting motor neurons. Early diagnosis is essential for the success of clinical trials and objective biomarkers are needed for monitoring disease progression. Nerve and muscle ultrasound may provide this informati...
What is the current status of trial NCT01785550?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2013-02. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01785550?
The interventions under investigation include: Ultrasound of nerve and muscle (OTHER).
Who is sponsoring clinical trial NCT01785550?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.